5th Annual mRNA Based Therapeutics Summit

Unlocking mRNA Vaccine, Therapeutics & Platform Technologies from Discovery to Commercialization With Targeted Extrahepatic Delivery, Dose Longevity & Improved Safety for Oncology, Rare & Infectious Diseases & Beyond

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval.

To shine light on emerging areas and the latest progress, the 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, gathering 350+ global stakeholders, sharing exclusive scientific and strategic insights from the biggest and newest players in the mRNA, Circular RNA & Self-Amplifying RNA fields including Moderna, Pfizer, BioNTech, Grann Pharmaceuticals, Celestial Therapeutics, Byterna Therapeutics and more.

Discover the realms of new infectious disease platforms, combating oncological targets and cell therapies across 4 dedicated tracks of content in Discovery, Pre-Clinical Development, Clinical Development and, Manufacturing & CMC as your one-stop-shop scientific content and partnering forum to aid the progress of pipelines in 2025 towards the clinic and ultimately patients in need.

Download Agenda

‍

Poster Presentation: 

TBD

Presented by

Abstract:  ‍